Pediatrix Medical Group Inc.

MD | NYSE

Price Alert Chart Builder DCF Calculator

$26.20

+$0.43 (+1.67%)

Sep 22, 2026, 10:23 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.67%

(1D)

Rating

Updated: Sep 18, 2026

54.1

Fundamentals Strong

Market Sentiment Neutral

Moat Narrow

Full Analysis

Key Statistics

Market Data

Market Cap $2.15B

1D Range

25.61 26.29

52W Range

15.70 27.94

Valuation (TTM)

PE 12.33

PB 2.40

EV/EBITDA 8.73

Valuation (NTM)

Forward PE 10.08

Forward PEG 3.06

Price Target $26.60

Cash Flow

FCF Yield 10.8%

SBC Adj. FCF Yield 9.9%

SBC Impact -8.8%

Margins

Gross Margin 25.9%

Operating Margin 11.6%

FCF Margin 11.7%

Growth (CAGR)

Revenue 3Y | 5Y -0.8% | 1.6%

Dil EPS 3Y | 5Y 19.0% | 44.1%

FCF 3Y | 5Y 18.1% | 17.4%

Returns

ROA 8.2%

ROE 19.9%

ROIC 9.6%

Financial Health

Net Debt

$180.05M

Current Ratio 1.32

Interest Coverage 8.01

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Pediatrix Medical Group, Inc. delivers specialized medical services for newborns, expectant mothers, and pediatric patients across the United States and Puerto Rico. The company offers crucial neonata...

Sector Healthcare

Industry Medical - Care Facilities

Employees 4,280

IPO Date Sep 19, 1995

Website www.pediatrix.com

Fiscal Year January - December

Full Company Profile

Latest News

4 days ago · defenseworld.net

Engineers Gate Manager LP Lowers Stock Position in Pediatrix Medical Group, Inc. $MD

Engineers Gate Manager LP trimmed its holdings in Pediatrix Medical Group, Inc. (NYSE: MD) by 60.9% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 49,871 shares of the company's stock after selling 77,533 shares during the quarter. Engineers Gate Manager LP

7 days ago · zacks.com

Why Pediatrix Medical Group (MD) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

19 days ago · zacks.com

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?

Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock?

21 days ago · zacks.com

Pediatrix Medical Group (MD) is a Top-Ranked Growth Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 month ago · zacks.com

Here's Why Pediatrix Medical Group (MD) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

1 month ago · zacks.com

Here's Why Pediatrix Medical Can Be a Smart Addition to Your Portfolio

MD's stronger cash collections, favorable payer mix, acquisitions and telehybrid care support its growth prospects.

1 month ago · zacks.com

Here's Why Pediatrix Medical Group (MD) is a Strong Growth Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 months ago · zacks.com

Pediatrix Medical Tops Q2 Earnings on Better Cash Collections

MD posts a Q2 earnings beat as stronger cash collections and a favorable payor mix lift results despite lower volumes.

2 months ago · marketbeat.com

Pediatrix Medical Group Q2 Earnings Call Highlights

Pediatrix Medical Group NYSE: MD reported second-quarter 2026 adjusted EBITDA of $76 million and reaffirmed its full-year adjusted EBITDA outlook of $280 million to $300 million, as stronger revenue-cycle-management collections, payer mix and patient acuity offset lower patient-service volumes.